Diabetes reduces vascular tetrahydrobiopterin levels by oxidation: Insights from a GTPCH-transgenic mouse model
主要な著者: | Alp, N, Mussa, S, Goh, N, Cai, S, Channon, K |
---|---|
フォーマット: | Conference item |
出版事項: |
2003
|
類似資料
-
Increased endothelial tetrahydrobiopterin levels in GTPCH-transgenic mice
著者:: Alp, N, 等
出版事項: (2002) -
Increased endothelial tetrahydrobiopterin levels by GTPCH over expression in transgenic mice prevents diabetic endothelial dysfunction
著者:: Alp, N, 等
出版事項: (2003) -
Reduced levels of tetrahydrobiopterin in diabetic mouse model: Effects on endothelial function and nitric oxide (NO) synthase dimerisation
著者:: Cai, S, 等
出版事項: (2004) -
Tetrahydrobiopterin-dependent preservation of nitric oxide-mediated endothelial function in diabetes by targeted transgenic GTP-cyclohydrolase I over-expression
著者:: Alp, N, 等
出版事項: (2003) -
Nitric oxide Bioavailability is preserved in diabetes by increased endothelial tetrahydrobiopterin synthesis in targeted GTP cyclohydrolase transgenic mice
著者:: Alp, N, 等
出版事項: (2003)